Early Anti-Smoking Drug Start Is Better, Study Says

In accordance with a preparatory research, financed by the Pfizer company, anti-smoking drug Chantix may help smokers to quit smoking.

Approximately a third of smoking people who tried Chantix drug a month before stopping smoking were absolutely smoke-free three months later. Those who only started Chantix are recommended to use this drug one week before they quit. Such people are nearly one in seven.

anti-smoking medication

anti-smoking medication

In spite of this, researchers have some doubts because the research was short and should be affirmed. They make sure of one thing – the drug may reduce smoking pleasure. It is one of Chantix’s effects. At the beginning smoking people will give up tobacco products to the fullest extent.

Peter Hajek of the UK Center for Tobacco Control Studies and colleagues made a comparison of the Chantix drug effect with making food look unattractive.

The researches underlined that the level of the Chantix drug effect and unattractive food may be the same, but it is easier to oppose a food than to have less temptation.

Chantix drug has been approved in the United States since 2006. However, information about suicidal thoughts and other mental health problems in people who used this drug led health professionals to order a black-box warning on the drug in 2009.

Medical options to Chantix, the costs for which are a few hundred dollars per month, contain nicotine patches and GlaxoSmithKline’s Zyban, which also has a black-box warning.

101 smokers of middle age from a quit-smoking clinic in London were examined by the researches. The scientists said to random half of them to start Chantix four weeks before quitting, while other smokers got a sugar pill for the first three weeks and then turned switch to Chantix as well.

At the end of the first three weeks, the participants on Chantix were smoking less and told that they did not have smoking pleasure as much as before. Nearly one in three of these smokers had reduced the number of cigarettes they smoked by half, compared to only one in ten of the people who began with sugar pills.

Participants from both groups had aversion. But nearly six in ten of the early-starters said that they had nausea at least one time during the study.

Dr. Joel A. Simon of the San Francisco VA Medical Center said that the new discovery is “exciting,” but it is necessary to undertake longer studies.

Dr. Joel A. Simon said that one in five Americans is a smoker and only 5 percent, of those who try to stop, have quitted smoking. Researchers counted up that half of all smokers die prematurely because of tobacco-related diseases.

He added that there is a sufficient evidence of positive effect of this drug and researches feel certain that tobacco-related misery will be reduced.

Similar Posts:

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>